Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide safety in acute ischemic stroke patients receiving intravenous thrombolysis
2013-001558-87Phase 2Terminated
- Sponsor
- Karolinska University Hospital
- Start
- Dec 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of exenatide in ischemic stroke (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Primary safety composite endpoint. Started Dec 2013; status: terminated.
02
Drugs
exenatide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2013-001558-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001558-87.